A Vancouver-based company, SaNOtize, has created a nasal spray that it says can stop COVID-19 from spreading throughout the body and even prevent someone from contracting the virus.
“The product is a nasal spray that can potentially prevent getting infected … and hopefully also treat disease early, in the early stages,” CEO and co-founder Dr Gilly Regev said on Monday at Global News.
The product, which uses nitric oxide, will begin clinical trials in the UK on Tuesday with patients who have tested positive for COVID-19.
The company was also recently approved to begin clinical trials in the United States and has completed the first Phase 2 trial in Canada where none of the 100 people treated with the spray contracted the virus, Regev said.
Israel is also considering defining the spray as a medical device and not a drug, she added, which means it could get approval in that country much faster.
The story continues under the ad
Coronavirus: Saint-Paul epidemic, provincial death rates
British Columbia exceeds 1,000 COVID-19 deaths as province adds 1,475 new cases
Studies suggest that nitric oxide can help prevent the virus from passing through the nose and into the respiratory system.
[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]
“It’s a liquid, made up of compounds that are used naturally in food, and when you combine them, they create a very small amount of nitric oxide,” explained Regev. “Nitric oxide is a molecule that we all have in our bodies… and it’s also approved to treat babies with breathing problems.”
Ontario government not currently considering a curfew, sources say
Canadian COVID-19 vaccine candidate: Medicago’s breakthrough, links to Big Tobacco, and pandemic warnings
Regev said they call it “the nose hand sanitizer” because it can be a preventative measure against infection if someone thinks they’ve been exposed to COVID-19.
She said the company had had conversations with Health Canada and was seeking government funding to conduct a larger clinical trial.
“We are very proud Canadians and we would just like to help. There is some frustration that it can’t go any faster [in Canada] but it’s like that now.
“So once we have the trial and the funding for the trial, we can move on.”
Variant strain of COVID-19 first discovered in UK detected in British Columbia
UK hospitals struggle as novel variant of coronavirus wreaks havoc
Such a trial, which would involve around 4,000 people, could take place in a few months after funding is secured, Regev added.
” It’s certain. We had no adverse events. It is very easy to use. It’s a simple nasal spray that everyone should have in their pocket.
Show link »
© 2021 Global News, a division of Corus Entertainment Inc.